| 1 |
2022 |
Georg Bauer, Friedhelm Struck, Eva Staschik, Julia Maile, Karin Wochinz‐Richter, Manfred Motz, Erwin Soutschek. Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity, Journal of Medical Virology. 2022; 94: 5294.
https://doi.org/10.1002/jmv.28006 |
| 2 |
2023 |
Amanda Izeli Portilho, Elizabeth De Gaspari. 2023;
https://doi.org/10.5772/intechopen.107908 |
| 3 |
2022 |
Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari. SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity, Clinics. 2022; 77: 100057100057.
https://doi.org/10.1016/j.clinsp.2022.100057 |
| 4 |
2022 |
Jonathon M. Monroe, Iana H. Haralambieva, Nathaniel D. Warner, Diane E. Grill, Huy Quang Quach, Richard B. Kennedy. Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection, Heliyon. 2022; 8: e11676e11676.
https://doi.org/10.1016/j.heliyon.2022.e11676 |
| 5 |
2023 |
Etsuhisa Takahashi, Takako Sawabuchi, Tetsuya Homma, Yosuke Fukuda, Hironori Sagara, Takeshi Kinjo, Kaori Fujita, Shigeru Suga, Takashi Kimoto, Satoko Sakai, Keiko Kameda, Hiroshi Kido. Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity, Viruses. 2023; 15: 1662.
https://doi.org/10.3390/v15081662 |
| 6 |
2023 |
Hernan H. M. da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro N. Duarte-Neto, Cinthya S. Cirqueira, Rodrigo A. Réssio, Cristina T. Kanamura, Karen Miguita, Jerenice E. Ferreira, Raimunda T. M. Santos, Patricia P. Adriani, Jair P. Cunha-Junior, Renato M. Astray, Regina M. Catarino, Marcelo Lancelotti, Carlos R. Prudencio. RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2, Viruses. 2023; 15: 555.
https://doi.org/10.3390/v15020555 |
